BRIDGET DUNN: Open Payments
NPI 1841706306 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$427 in 20 payments from 10 companies in 2025. Trend: 2023 $1,018 · 2024 $1,172 · 2025 $427
Food & beverage: $427
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 4 | $101 |
| Novo Nordisk Inc | 3 | $68 |
| AstraZeneca Pharmaceuticals LP | 4 | $65 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $63 |
| Lilly USA, LLC | 2 | $42 |
| ABBVIE INC. | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| Inspire Medical Systems, Inc. | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Amgen Inc. | 1 | $15 |
Products named: Veozah, CAPLYTA, Ozempic, MOUNJARO, BREZTRI, AIRSUPRA, VRAYLAR, JARDIANCE.
Industry payments across PA — which companies pay providers there.
